Tural, D. Et Al. 2024. Immune Checkpoint Blockade Therapies Efficacy and Toxicity in Patients With Impaired Renal Function in Metastatic Bladder Cancer. CLINICAL GENITOURINARY CANCER , vol.22, no.6 .

Tural, D., Arslan, C., Selcukbiricik, F., Olmez, O. F., Akar, E., ERMAN, M., ... Ueruen, Y.(2024). Immune Checkpoint Blockade Therapies Efficacy and Toxicity in Patients With Impaired Renal Function in Metastatic Bladder Cancer. CLINICAL GENITOURINARY CANCER , vol.22, no.6.

Tural, Deniz Et Al. "Immune Checkpoint Blockade Therapies Efficacy and Toxicity in Patients With Impaired Renal Function in Metastatic Bladder Cancer," CLINICAL GENITOURINARY CANCER , vol.22, no.6, 2024

Tural, Deniz Et Al. "Immune Checkpoint Blockade Therapies Efficacy and Toxicity in Patients With Impaired Renal Function in Metastatic Bladder Cancer." CLINICAL GENITOURINARY CANCER , vol.22, no.6, 2024

Tural, D. Et Al. (2024) . "Immune Checkpoint Blockade Therapies Efficacy and Toxicity in Patients With Impaired Renal Function in Metastatic Bladder Cancer." CLINICAL GENITOURINARY CANCER , vol.22, no.6.

@article{article, author={Deniz Tural Et Al. }, title={Immune Checkpoint Blockade Therapies Efficacy and Toxicity in Patients With Impaired Renal Function in Metastatic Bladder Cancer}, journal={CLINICAL GENITOURINARY CANCER}, year=2024}